PairBook
HomeStocks › ABUS

ABUS correlations (Arbutus Biopharma Corporation)

Which assets move with ABUS and which ones diversify it, computed from weekly returns across 4756 stocks and ETFs.

Data as of 2026-08-27 · refreshed every trading day · US Listed

Volatility (ann.)
41.5%
3y weekly
Beta vs S&P 500
0.46
3y weekly
1-year return
+41.6%
price, adjusted
5-year return
+53.0%
price, adjusted
Market cap
$1.0B
latest
P/E ratio
6.5
trailing
Max drawdown
-36.8%
3y, daily closes
-9%0%+24%2025-09-052026-08-27
ABUS over the last 12 months, weekly closes indexed to 100 at the start.

Stocks and ETFs most correlated with ABUS

AssetCorrelation (3Y)
TVTXTravere Therapeutics, Inc.0.42
ROIVRoivant Sciences Ltd.0.42
FDMT4D Molecular Therapeutics, Inc.0.41
RAREUltragenyx Pharmaceutical Inc.0.41
XBISPDR S&P Biotech ETF0.40

Best diversifiers for ABUS

These are the assets whose returns had the least to do with ABUS's, historically the most independent picks in our universe.

AssetCorrelation (3Y)
POETPOET Technologies Inc.-0.23
DCXDigital Currency X Technology Inc. - Class A-0.21
LIVELive Ventures Incorporated-0.18

ABUS vs benchmarks

Get ABUS data as JSON

Free API · no key required
$ curl https://www.pairbook.io/api/v1/symbols/abus.json

Correlations, diversifiers, beta and volatility for ABUS, plus one endpoint per pair. API documentation.

ABUS inside major ETFs

ETFABUS weight
IBBiShares Biotechnology ETF0.06%